[CAS NO. 1428862-33-2]  Usmarapride

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1428862-33-2]

Catalog
AS965033
Brand
Arctom Scientific
CAS
1428862-33-2

DESCRIPTION [1428862-33-2]

Overview

MDL-
Molecular Weight473.52
Molecular FormulaC23H31N5O6
SMILESCC(N1N=C(C2=NN=C(C3CCN(CCCOC)CC3)O2)C4=C1C=CC=C4)C.O=C(O)C(O)=O

For research use only. We do not sell to patients.

Summary

Usmarapride (SUVN-D4010) is a potent, selective, orally active and brain penetrant 5-HT 4 receptor partial agonist ( EC 50 =44 nM). Usmarapride (SUVN-D4010) can be used for the research of cognitive deficits associated with Alzheimer's disease [1] .


IC50 & Target

5-HT 4 Receptor

44 nM (EC 50 )


In Vivo

Usmarapride (SUVN-D4010) (1-3 mg/kg; p.o.; Male Wistar rats 10-12 weeks old) attenuates the long-term memory deficits in object recognition test (ORT) [1] .
Usmarapride (1, 3, and 10 mg/kg; p.o.) significantly reverses the scopolamine-induced amnesia [1] .
Usmarapride shows a statistically significant effect at 3.0 mg/kg on both exploration time and recognition index [1] .
Usmarapride (SUVN-D4010) shows good oral exposures, good bioavailability, and good brain exposures in rats [1] .
Pharmacokinetic of Usmarapride in Rats [1]
(3.0 mg/kg for p.o. dosing; 1.0 mg/kg for i.v.)

F% C max (ng/mL) AUC (ng·hr/mL) t 1/2 (h) V dss (L/kg) CL (mLg/min/kg)
34 360 709 1.7 8.0 76

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Clinical Trial

NCT Number Sponsor Condition Start Date Phase
NCT02575482 Suven Life Sciences Limited
Cognitive Disorders
July 2015 Phase 1
NCT03031574 Suven Life Sciences Limited
Cognitive Disorder
January 23, 2017 Phase 1

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

DMSO : 33.33 mg/mL ( 70.39 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.1118 mL 10.5592 mL 21.1184 mL
5 mM 0.4224 mL 2.1118 mL 4.2237 mL
10 mM 0.2112 mL 1.0559 mL 2.1118 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: 2.5 mg/mL (5.28 mM); Suspended solution; Need ultrasonic

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (5.28 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.5 mg/mL (5.28 mM); Clear solution

* All of the co-solvents are available by MCE.